Article
Commentary: Vaginal Estrogen Therapy, ILC, And Oral Estrogen Receptor Degraders In Breast Cancer, December 2023
- Author:
- Yara Abdou, MD
Publish date: November 29, 2023
Article
Commentary: PMRT and New Treatments for Metastatic BC, November 2023
- Author:
- Yara Abdou, MD
Publish date: November 1, 2023
Article
Commentary: New treatments and trial results, October 2023
- Author:
- Yara Abdou, MD
Publish date: September 29, 2023
Article
Commentary: Alcohol, PPI use, BMI, and lymph node dissection in BC, September 2023
- Author:
- Yara Abdou, MD
Publish date: August 31, 2023
Article
Commentary: Meningioma, Radiotherapy Interruptions, Therapy Persistence, and Lymphocytes in BC, August 2023
- Author:
- Yara Abdou, MD
Publish date: July 26, 2023
Article
Commentary: CDK4/6 Inhibitors, Breast Irradiation, and Aromatase Inhibitors in Breast Cancer Treatment, July 2023
- Author:
- Yara Abdou, MD
Publish date: June 29, 2023
Article
Commentary: Trastuzumab, breast density, and extended treatment in BC, June 2023
- Author:
- Yara Abdou, MD
Publish date: May 30, 2023
Article
Commentary: Surgical, Tamoxifen, and Genetic Considerations in Breast Cancer, May 2023
- Author:
- Yara Abdou, MD
Publish date: May 1, 2023
Article
Commentary: Alisertib, trastuzumab, and treatment timing, April 2023
- Author:
- Yara Abdou, MD
Publish date: March 29, 2023
Article
Commentary: Looking at Treatment Regimens for HR+ Breast Cancer and Triple-Negative Breast Cancer, March 2023
- Author:
- Yara Abdou, MD
Publish date: March 1, 2023
Article
Commentary: Genetic variants, ovarian suppression, and metabolic syndrome in BC, February 2023
- Author:
- Yara Abdou, MD
Publish date: January 31, 2023
Article
Commentary: New Drugs, and Exercise, in Breast Cancer January 2023
- Author:
- Yara Abdou, MD
Publish date: January 6, 2023
Article
Treatment of HER2-Low Breast Cancer
- Author:
- Yara Abdou, MD
Publish date: November 1, 2022
Article
Commentary: Combination Chemotherapies, September 2022
- Author:
- Yara Abdou, MD
Publish date: September 1, 2022
Article
Commentary: Looking at Therapies for Patients With HER2-low Breast Cancer, August 2022
- Author:
- Yara Abdou, MD
Publish date: July 29, 2022